BioForce Nanosciences Holdings, Inc.
BFNH
$1.79
$0.010.56%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 117.70K | 117.80K | 115.90K | 122.80K | 133.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 117.70K | 117.80K | 115.90K | 122.80K | 133.50K |
| Operating Income | -117.70K | -117.80K | -115.90K | -122.80K | -133.50K |
| Income Before Tax | -102.40K | -118.60K | -115.90K | -122.80K | -935.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -102.40K | -118.60K | -115.90K | -122.80K | -935.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -102.40K | -118.60K | -115.90K | -122.80K | -935.50K |
| EBIT | -117.70K | -117.80K | -115.90K | -122.80K | -133.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 33.52M | 33.53M | 33.52M | 33.52M | 32.25M |
| Average Diluted Shares Outstanding | 33.52M | 33.53M | 33.52M | 33.52M | 32.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |